Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-10-06
1996-01-09
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540555, C07D49522, A61K 3155
Patent
active
054829372
ABSTRACT:
A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are useful in the pharmaceutical field, especially in treating allergic diseases. ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.
REFERENCES:
patent: 4959361 (1990-09-01), Walser
patent: 4960770 (1990-10-01), Moriwoki et al.
patent: 4968794 (1990-11-01), Weber et al.
patent: 5049559 (1991-09-01), Braquet et al.
patent: 5049560 (1991-09-01), Esanu et al.
Tsunoda et al., Chemical Abstract vol. 114, No. 5 5582U (1990).
Abe Shinya
Asano Osamu
Clark Richard S. J.
Harada Koukichi
Katayama Kouichi
Datlow Philip I.
Eisai Co. Ltd.
LandOfFree
1,4-diazepine derivative and its pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-diazepine derivative and its pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-diazepine derivative and its pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1303257